Morphle Labs makes its ceremonial 101st microscope slide scanner for NIH’s National Cancer Institute. It customized the Digital Pathology Scanner to fit the research needs of NCI. Morphle Labs, a MedTech startup founded in 2017, positions its products as the best in smartness, simplicity, and robustness.

At NIH, the 6-slide Optimus 6X Digital Pathology slide scanner will be used in Dr. Patricia Steeg’s lab for counting brain metastases of several breast cancer lines (4T1-BR5, MDA-MB-231Br, etc.) using the whole slide scanner where they are attempting to assess the metastasis frequency and drug treatment on breast cancer metastasis to the brain under the guidance of Dr. Imran Khan who specializes in breast cancer metastasis. The microscope slide scanner will be used for scanning regular slides as well as counting the number of Mets in the mouse brain, and measuring these Mets using Digital Pathology.

Its fundamental pitch, as Mr. S. Daniel says, is “with growing possibilities opening up for the pathology community, you need a partner who understands your needs and can keep you as a priority over themselves. Morphle is that customer-centric company that strives for customer success.”

He continues, “Our friends at NIH were using a scanner that expected people’s lives to revolve around it. We just flipped the switch, and made our scanner revolve around their lives!”

Some of the other things that Mr. S. Daniel says which the people at NIH liked are:

1. It is not a black box whole slide scanning solution: Creating closed black boxes has been the norm in pathology. However, Morphle Digital Pathology slide scanners allow you to add features that let you innovate.

2. 0% slide rejections: Morphle microscope slide scanners do not reject slides for not having the right stain or for not being the right kind of slide. They scan all the slides with a 100% success rate!

‍Would you like to have a customized Digital Pathology Slide Scanner to fit your research needs too? Get in touch with us!